ALAN J MAIN
CIK 1227372 · EVP, Innov & Chem Sciences · last filed 2025-03-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$540.3K
Companies
2
Total Filings
37
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LXRX | EVP, Innov & Chem Sciences | 281,391 | $1.92 | $540.3K | $0 | 36 | 2025-03-03 |
| LEXICON PHARMACEUTICALS, INC. (LEXG) Delisted | EVP, Pharmaceutical Research | — | — | — | $0 | 1 | 2007-02-15 |
Recent Filings · Page 3 of 4
37 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-02-16 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2015-03-03 | LXRX | Mixed | +43,682 | -$23.8K | EDGAR |
| 2015-02-09 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2014-03-03 | LXRX | Mixed | +31,582 | -$35.8K | EDGAR |
| 2014-02-10 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2013-03-01 | LXRX | Mixed | +21,178 | -$24.9K | EDGAR |
| 2013-02-12 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2013-02-04 | LXRX | Mixed | +19,063 | -$26.5K | EDGAR |
| 2012-03-01 | LXRX | Mixed | +10,343 | -$10.5K | EDGAR |
| 2012-02-17 | LXRX | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.